Коефициентът на вероятност (HR) по отношение на свободната от прогресия преживяемост (СПП) е 1, 00 (95% CI за HR = 0, 82- 1, 22).
The protocol-specified objective of demonstrating non-inferiority between Caelyx and doxorubicin was met, the hazard ratio (HR) for progression-free survival (PFS) was 1.00 (95% CI for HR=0.82 - 1.22).